Annual report
3840.TEDINET S100UCIM
Period2022-04-01 → 2023-03-31
Filed2024-09-11
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100RAZA.
Key figures · 134
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥2.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.7bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥220m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | −¥682m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | −¥224m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥737m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥538m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥873m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥253m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥743m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥256m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥746m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥538m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥778m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥157m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥256m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | −¥746m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥1.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.1bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.2bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.7bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥351m | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥802m | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥470m | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥673m | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥743m | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.5bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥173m | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥345m | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥173m | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥345m | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥206m | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥252m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥822m | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥352m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥836m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥502m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥346m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥210m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥114m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥24m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥2m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥248m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥517m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥281m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥999m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥454m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥472m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥145m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-5.46 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.95 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.36 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-27.54 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.58 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥20.91 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥12.4 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥21.19 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥26.32 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥53.86 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 74.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.4% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.6% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 56 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 50 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 50 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 46 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 44 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥132m | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥95m | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥119m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥35m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥42m | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥119m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | −¥169m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥268m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥666m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥341m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥462m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥97m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥298m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥1.1bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥298m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥1.1bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | −¥632m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥494m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥98m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥946m | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥982m | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥1.2bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.0bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥24m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥649m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥922m | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥334m | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥879m | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.5bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥68m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥215m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-6.36 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-30.54 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.55 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.49 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.48 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥17.46 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥8.73 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥27.71 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥36.94 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥54.43 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 95.1% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.2% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 51,509,516 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 36,944,500 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 31,625,800 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 28,240,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 28,240,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 4 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 12 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 10 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 3 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 2 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 27
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥103m |
| Cosmetics Beauty And Wellnes Businessreportable segment | employees | at 2023-03-31 | 38 pure |
| Cosmetics Beauty And Wellnes Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Cosmetics Beauty And Wellnes Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Cosmetics Beauty And Wellnes Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥5m |
| Cosmetics Beauty And Wellnes Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥64m |
| Sustainable Regenerative Medicine Related Businessreportable segment | employees | at 2023-03-31 | 14 pure |
| Sustainable Regenerative Medicine Related Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥57m |
| Sustainable Regenerative Medicine Related Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥57m |
| Sustainable Regenerative Medicine Related Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥200,000 |
| Sustainable Regenerative Medicine Related Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥53m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥5m |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | −¥117m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥45m |
| Cosmetics Beauty And Wellnes Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.1bn |
| Cosmetics Beauty And Wellnes Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.1bn |
| Cosmetics Beauty And Wellnes Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥542m |
| Sustainable Regenerative Medicine Related Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥450,000 |
| Sustainable Regenerative Medicine Related Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥450,000 |
| Sustainable Regenerative Medicine Related Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥95m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥2.1bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥2.1bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | −¥637m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,128
| Item | Context | Value | Unit |
|---|---|---|---|
| Salaries and allowances sga | CurrentYearDuration_NonConsolidatedMember | 22736000 | JPY |
| Consulting expenses sga | Prior1YearDuration_NonConsolidatedMember | 45101000 | JPY |
| Consulting expenses sga | CurrentYearDuration_NonConsolidatedMember | 37037000 | JPY |
| Provision for bonuses ga | Prior1YearDuration_NonConsolidatedMember | 341000 | JPY |
| Provision for bonuses ga | CurrentYearDuration_NonConsolidatedMember | 1678000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration_NonConsolidatedMember | 31809000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書（2024年９月11日付け訂正報告書の添付インラインXBRL） | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-06-30 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第33期（自 2022年４月１日 至 2023年３月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)パス株式会社 | |
| Company name in english cover page | FilingDateInstant | PATH corporation | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 高橋 勇造 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都渋谷区神宮前六丁目17番11号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03（6823）6664（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 星 淳行 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都渋谷区神宮前六丁目17番11号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03（6823）6664（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 星 淳行 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05674 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 38400 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)パス株式会社 | |
| Filer name in english | FilingDateInstant | PATH corporation | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2023-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | true | |
| Identification of document subject to amendment | FilingDateInstant | S100RAZA | |
| Report amendment flag | FilingDateInstant | true | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |